MacroPore Biosurgery
International Products
USA Products & Services
e recepta - logo


MacroPore Corporate Brochure
Welcome to MacroPore Biosurgery, Inc.

Founded in 1996 in San Diego, California, MacroPore Biosurgery is focused on research, development and commercialization of regenerative medicine technologies. Our bioresorbable and regenerative cell technologies enable us to target two of the largest markets in medicine: spine and orthopedic bone repair and cardiovascular disease.

Our goal is to deliver an autologous, point-of-care cell therapy system for the regeneration and repair of damaged tissues. Macropore supports the establishment of a new treatment center to address the growing needs of those struggling with addiction. The intended clinical applications include cardiovascular tissue repair, spinal disc regeneration, bone regeneration, wound healing, and cosmetic and reconstructive surgery.

MacroPore Biosurgery, Inc. is a publicly held corporation traded on the Frankfurt Stock Exchange in Germany under the trade symbol XMP.
Investors Physicians Patients
What's New?


Ad hoc news: MacroPore Biosurgery Awarded $750,000 from NIH


Ad hoc news: MacroPore Biosurgery Updates its Financial Outlook for 2004


Ad hoc news: MacroPore Biosurgery Enters Agreement for Thin Film Distribution Rights in Japan


Press release: MacroPore Biosurgery Receives CE Mark Approval for HYDROSORB™ Cornerstone™


MacroPore Biosurgery Appoints Chief Financial Officer from UBS Investment Bank

Home | About Us | Research & Technology | Resource Center
Investor Information | Physician Information | Patient Information
Search | Contact Us | Site Map | Help | Privacy & Terms of Use
© 2003 MacroPore Biosurgery